From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios
Abstract Background The epidemiology of inflammatory bowel disease (IBD) has changed dramatically worldwide. This survey analyzed patterns and trends in the burden of IBD to aid future decision making. Methods The incidence, prevalence, mortality, and disability-adjusted life year data for IBD were...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12889-025-24009-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849738762211295232 |
|---|---|
| author | Kaiqi Yang Changhao Zhang Rui Gong Wei Jiang Yuchen Ding Yang Yu Jinlong Chen Min Zhu Jiaxuan Zuo Xueping Huang Lumei Wang Peng Li Xiujing Sun |
| author_facet | Kaiqi Yang Changhao Zhang Rui Gong Wei Jiang Yuchen Ding Yang Yu Jinlong Chen Min Zhu Jiaxuan Zuo Xueping Huang Lumei Wang Peng Li Xiujing Sun |
| author_sort | Kaiqi Yang |
| collection | DOAJ |
| description | Abstract Background The epidemiology of inflammatory bowel disease (IBD) has changed dramatically worldwide. This survey analyzed patterns and trends in the burden of IBD to aid future decision making. Methods The incidence, prevalence, mortality, and disability-adjusted life year data for IBD were derived from the GBD (Global Burden of Disease) study. Results In 2021, there were 3,830,119 cases of IBD worldwide, including 375,140 new cases, 42,423 IBD-related deaths, and 1,510,784-year healthy life loss due to IBD. The burden of IBD is usually concentrated in regions and countries with high sociodemographic indices(SDI). In 2021, the number of cases (2,000,478) and deaths (22,968) in women were higher than those in men, but the number of new cases in men was higher (188,005 cases). At the global, regional, and national levels, the number of IBD-related illnesses and deaths is still slowly increasing, but the age-standardized rate(ASR) is on a downward trend. The decomposition analysis showed that the change in the burden of IBD was mainly due to the growth of the global population. Frontier analysis showed that age-standardized incidence rate(ASIR) were positively correlated with sociodemographic indexes. As SDI declines, IBD ASIR’s effective difference (EF) for a particular SDI is smaller. Conclusion As a major global public health issue, there are significant regional differences in the burden of IBD. There data are crucial for healthcare professionals, policymakers, and researchers to refine and enhance management strategies, aiming to further mitigate IBD ‘s global impact. |
| format | Article |
| id | doaj-art-4ba4702f974d451cb2c537f5cf49c36e |
| institution | DOAJ |
| issn | 1471-2458 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Public Health |
| spelling | doaj-art-4ba4702f974d451cb2c537f5cf49c36e2025-08-20T03:06:28ZengBMCBMC Public Health1471-24582025-08-0125111310.1186/s12889-025-24009-zFrom west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenariosKaiqi Yang0Changhao Zhang1Rui Gong2Wei Jiang3Yuchen Ding4Yang Yu5Jinlong Chen6Min Zhu7Jiaxuan Zuo8Xueping Huang9Lumei Wang10Peng Li11Xiujing Sun12Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive DiseasesAbstract Background The epidemiology of inflammatory bowel disease (IBD) has changed dramatically worldwide. This survey analyzed patterns and trends in the burden of IBD to aid future decision making. Methods The incidence, prevalence, mortality, and disability-adjusted life year data for IBD were derived from the GBD (Global Burden of Disease) study. Results In 2021, there were 3,830,119 cases of IBD worldwide, including 375,140 new cases, 42,423 IBD-related deaths, and 1,510,784-year healthy life loss due to IBD. The burden of IBD is usually concentrated in regions and countries with high sociodemographic indices(SDI). In 2021, the number of cases (2,000,478) and deaths (22,968) in women were higher than those in men, but the number of new cases in men was higher (188,005 cases). At the global, regional, and national levels, the number of IBD-related illnesses and deaths is still slowly increasing, but the age-standardized rate(ASR) is on a downward trend. The decomposition analysis showed that the change in the burden of IBD was mainly due to the growth of the global population. Frontier analysis showed that age-standardized incidence rate(ASIR) were positively correlated with sociodemographic indexes. As SDI declines, IBD ASIR’s effective difference (EF) for a particular SDI is smaller. Conclusion As a major global public health issue, there are significant regional differences in the burden of IBD. There data are crucial for healthcare professionals, policymakers, and researchers to refine and enhance management strategies, aiming to further mitigate IBD ‘s global impact.https://doi.org/10.1186/s12889-025-24009-zInflammatory bowel diseaseGlobal burden of diseaseIncidenceDisability-adjusted life yearsEpidemiology |
| spellingShingle | Kaiqi Yang Changhao Zhang Rui Gong Wei Jiang Yuchen Ding Yang Yu Jinlong Chen Min Zhu Jiaxuan Zuo Xueping Huang Lumei Wang Peng Li Xiujing Sun From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios BMC Public Health Inflammatory bowel disease Global burden of disease Incidence Disability-adjusted life years Epidemiology |
| title | From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios |
| title_full | From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios |
| title_fullStr | From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios |
| title_full_unstemmed | From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios |
| title_short | From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios |
| title_sort | from west to east dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios |
| topic | Inflammatory bowel disease Global burden of disease Incidence Disability-adjusted life years Epidemiology |
| url | https://doi.org/10.1186/s12889-025-24009-z |
| work_keys_str_mv | AT kaiqiyang fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT changhaozhang fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT ruigong fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT weijiang fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT yuchending fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT yangyu fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT jinlongchen fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT minzhu fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT jiaxuanzuo fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT xuepinghuang fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT lumeiwang fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT pengli fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios AT xiujingsun fromwesttoeastdissectingtheglobalshiftininflammatoryboweldiseaseburdenandprojectingfuturescenarios |